These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16995895)

  • 81. Structural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding protein.
    Bernhards RC; Jing X; Vogelaar NJ; Robinson H; Schubot FD
    Protein Sci; 2009 Mar; 18(3):503-13. PubMed ID: 19235906
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes.
    Okkotsu Y; Little AS; Schurr MJ
    Front Cell Infect Microbiol; 2014; 4():82. PubMed ID: 24999454
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Type 3 secretion system as an anti-Pseudomonal target.
    Horna G; Ruiz J
    Microb Pathog; 2021 Jun; 155():104907. PubMed ID: 33930424
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Type III secretion system expression in oxygen-limited Pseudomonas aeruginosa cultures is stimulated by isocitrate lyase activity.
    Chung JC; Rzhepishevska O; Ramstedt M; Welch M
    Open Biol; 2013 Jan; 3(1):120131. PubMed ID: 23363478
    [TBL] [Abstract][Full Text] [Related]  

  • 85. FimL regulates cAMP synthesis in Pseudomonas aeruginosa.
    Inclan YF; Huseby MJ; Engel JN
    PLoS One; 2011 Jan; 6(1):e15867. PubMed ID: 21264306
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Structure-Function-Inhibition Analysis of the
    Moir DT; Bowlin NO; Berube BJ; Yabut J; Mills DM; Nguyen GT; Aron ZD; Williams JD; Mecsas J; Hauser AR; Bowlin TL
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32601072
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Perspectives on the
    Hardy KS; Tessmer MH; Frank DW; Audia JP
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941717
    [No Abstract]   [Full Text] [Related]  

  • 88. Two-component systems required for virulence in Pseudomonas aeruginosa.
    Francis VI; Stevenson EC; Porter SL
    FEMS Microbiol Lett; 2017 Jun; 364(11):. PubMed ID: 28510688
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of Pseudomonas aeruginosa ExsA DNA-Binding Activity by N-Hydroxybenzimidazoles.
    Marsden AE; King JM; Spies MA; Kim OK; Yahr TL
    Antimicrob Agents Chemother; 2016 Feb; 60(2):766-76. PubMed ID: 26574012
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
    Elsen S; Huber P; Bouillot S; Couté Y; Fournier P; Dubois Y; Timsit JF; Maurin M; Attrée I
    Cell Host Microbe; 2014 Feb; 15(2):164-76. PubMed ID: 24528863
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Control of type III secretion activity and substrate specificity by the cytoplasmic regulator PcrG.
    Lee PC; Zmina SE; Stopford CM; Toska J; Rietsch A
    Proc Natl Acad Sci U S A; 2014 May; 111(19):E2027-36. PubMed ID: 24778208
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intrinsic and Extrinsic Regulation of Type III Secretion Gene Expression in Pseudomonas Aeruginosa.
    Diaz MR; King JM; Yahr TL
    Front Microbiol; 2011; 2():89. PubMed ID: 21833328
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Self-trimerization of ExsD limits inhibition of the Pseudomonas aeruginosa transcriptional activator ExsA in vitro.
    Bernhards RC; Marsden AE; Esher SK; Yahr TL; Schubot FD
    FEBS J; 2013 Feb; 280(4):1084-94. PubMed ID: 23279839
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Low oxygen induces the type III secretion system in Pseudomonas aeruginosa via modulation of the small RNAs rsmZ and rsmY.
    O'Callaghan J; Reen FJ; Adams C; O'Gara F
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3417-3428. PubMed ID: 21873408
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HigB of
    Li M; Long Y; Liu Y; Liu Y; Chen R; Shi J; Zhang L; Jin Y; Yang L; Bai F; Jin S; Cheng Z; Wu W
    Front Cell Infect Microbiol; 2016; 6():125. PubMed ID: 27790409
    [TBL] [Abstract][Full Text] [Related]  

  • 96. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection.
    Zhao K; Li W; Li J; Ma T; Wang K; Yuan Y; Li JS; Xie R; Huang T; Zhang Y; Zhou Y; Huang N; Wu W; Wang Z; Zhang J; Yue B; Zhou Z; Li J; Wei YQ; Zhang X; Zhou X
    Nat Microbiol; 2019 Mar; 4(3):459-469. PubMed ID: 30617346
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Human Tear Fluid Reduces Culturability of Contact Lens-Associated Pseudomonas aeruginosa Biofilms but Induces Expression of the Virulence-Associated Type III Secretion System.
    Wu YT; Tam C; Zhu LS; Evans DJ; Fleiszig SM
    Ocul Surf; 2017 Jan; 15(1):88-96. PubMed ID: 27670247
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Regulation of type III secretion system in Pseudomonas syringae.
    Xie Y; Shao X; Deng X
    Environ Microbiol; 2019 Dec; 21(12):4465-4477. PubMed ID: 31408268
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pseudomonas aeruginosa two-component system CprRS regulates HigBA expression and bacterial cytotoxicity in response to LL-37 stress.
    Song Y; Zhang S; Zhao N; Nong C; He Y; Bao R
    PLoS Pathog; 2024 Jan; 20(1):e1011946. PubMed ID: 38198506
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Intracellular replication of
    Kroken AR; Klein KA; Mitchell PS; Nieto V; Jedel EJ; Evans DJ; Fleiszig SMJ
    mSphere; 2023 Oct; 8(5):e0035123. PubMed ID: 37589460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.